ASSET | DATE | % RETURN |
---|---|---|
Poseida Therapeutics (PSTX) | 11/25/2024 - 12/2/2024 | 231.67% |
Logistic Properties of the Americas (LPA) | 11/25/2024 - 12/2/2024 | 101.54% |
Innoviz Technologies (INVZW) | 11/25/2024 - 12/2/2024 | 87.8% |
Renovaro Biosciences (RENB) | 11/25/2024 - 12/2/2024 | 62.89% |
Microvast (MVST) | 11/25/2024 - 12/2/2024 | 58.52% |
Hesai Group American Depositary Share, each ADS represents one Class B ordinary share (HSAI) | 11/25/2024 - 12/2/2024 | 57.2% |
Lexinfintech (LX) | 11/25/2024 - 12/2/2024 | 50.43% |
Embecta (EMBC) | 11/25/2024 - 12/2/2024 | 48.34% |
Blade Air Mobility (BLDEW) | 11/25/2024 - 12/2/2024 | 45.71% |
Verve Therapeutics (VERV) | 11/25/2024 - 12/2/2024 | 44.35% |
Adaptive Biotechnologies (ADPT) | 11/25/2024 - 12/2/2024 | 35.76% |
Blade Air Mobility (BLDE) | 11/25/2024 - 12/2/2024 | 31.95% |
Rezolve AI Limited Ordinary Shares (RZLV) | 11/25/2024 - 12/2/2024 | 31.05% |
Dana (DAN) | 11/25/2024 - 12/2/2024 | 30.98% |
Ginkgo Bioworks (DNA) | 11/25/2024 - 12/2/2024 | 29.69% |
Delcath Systems (DCTH) | 11/25/2024 - 12/2/2024 | 28.98% |
Eastman Kodak (KODK) | 11/25/2024 - 12/2/2024 | 28.7% |
Satellogic V (SATL) | 11/25/2024 - 12/2/2024 | 28.57% |
Immunome (IMNM) | 11/25/2024 - 12/2/2024 | 26.85% |
Evolv Technologies (EVLV) | 11/25/2024 - 12/2/2024 | 26.52% |
Eos Energy Enterprises (EOSEW) | 11/25/2024 - 12/2/2024 | 26.47% |
SolarEdge Technologies (SEDG) | 11/25/2024 - 12/2/2024 | 26.41% |
Qudian (QD) | 11/25/2024 - 12/2/2024 | 26.07% |
DouYu International (DOYU) | 11/25/2024 - 12/2/2024 | 25.39% |
Sangamo Therapeutics (SGMO) | 11/25/2024 - 12/2/2024 | 24.21% |